Compare Stocks → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:ARATSE:SEC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsSECSenvest CapitalC$290.00C$292.71C$280.00▼C$327.51C$716.30M0.81280 shsN/A7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%SECSenvest Capital0.00%0.00%+1.75%-9.02%-3.33%Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARAAmerican Renal AssociatesN/AN/AN/AN/AN/AN/AN/AN/ASECSenvest CapitalN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARAAmerican Renal AssociatesN/AN/AN/AN/ASECSenvest CapitalN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARAAmerican Renal Associates$822.52M0.48$1.69 per share6.80$2.59 per share4.45SECSenvest CapitalC$612.76M1.17C$1,504.93 per share0.19C$634.25 per share0.46Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARAAmerican Renal Associates-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/ASECSenvest CapitalC$151.74M-C$84.10N/A∞N/A24.76%10.04%6.62%5/14/2024 (Estimated)Latest CLIG, RYD, SEC, and ARA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/28/2024Q4 2023SECSenvest CapitalN/AC$34.61+C$34.61C$34.61N/AC$166.73 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARAAmerican Renal AssociatesN/AN/AN/AN/AN/ASECSenvest CapitalN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARAAmerican Renal Associates7.541.051.02SECSenvest Capital56.891.351.31OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARAAmerican Renal Associates78.42%SECSenvest CapitalN/AInsider OwnershipCompanyInsider OwnershipARAAmerican Renal Associates9.50%SECSenvest Capital60.53%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableARAAmerican Renal Associates4,97734.54 millionN/AOptionableSECSenvest Capital322.47 millionN/ANot OptionableCLIG, RYD, SEC, and ARA HeadlinesSourceHeadlineElon Musk May Be Compelled to Testify Again in SEC's Twitter Takeover Probemsn.com - May 9 at 6:54 PMHouse to vote on whether to overturn SEC guidance on crypto custodymsn.com - May 9 at 9:30 AMRobinhood Crypto Warned of Coming SEC Actioninc.com - May 8 at 3:37 AMColumn: Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SECreuters.com - May 7 at 5:35 PMThe SEC Is Playing Target Practice With Crypto Businessesinc.com - May 7 at 12:34 PMClosing Bell: Senvest Capital up on Monday (SEC)theglobeandmail.com - May 7 at 2:34 AMHedge Start: When Is SEC Registration Necessary?natlawreview.com - May 6 at 9:33 PMSEC, Stakeholders to Brainstorm on Critical Capital Market Issuesthisdaylive.com - May 6 at 9:55 AMSVB agrees to sell venture capital arm for $340 millionmsn.com - May 3 at 9:02 PMGlobal Regulatory Brief: Trading and markets, May editionbloomberg.com - May 3 at 9:02 PMSVB Financial to sell VC business SVB Capitalmsn.com - May 3 at 2:07 AMSenvest Capital (TSE:SEC) Trading 1.8% Higher marketbeat.com - April 30 at 12:22 AMCornerstone investment regulations issued by SECmsn.com - April 26 at 12:57 PMSEC sued over Ethereum, crypto firm asks court to state token is not a securitymsn.com - April 26 at 7:57 AMSEC Unveils Groundbreaking Report Revealing $26 Trillion in Registered Funds to Foster Transparencyhoodline.com - April 26 at 7:57 AMRegulators Impose Extraordinary Fine Amounts in Recent Off-Channel Communications Enforcement Actionsjdsupra.com - April 24 at 8:49 PMSEC Settles Charges with Investment Adviser for Off-Channel Communications Recordkeeping Failuresjdsupra.com - April 24 at 8:49 PMFund offering ‘venture capital’ exposure sends investors on meme-like ridekfgo.com - April 24 at 12:09 AMSenvest Management Enforcement Action – Electronic Communicationsjdsupra.com - April 15 at 11:12 PMSATRIX Collective Investment Scheme Expands Portfolio with New Securities Listingmsn.com - April 12 at 10:22 AMSEC to sue Uniswap DEX amid DeFi regulatory crackdownfinancefeeds.com - April 11 at 1:45 PMSEC Warns DeFi Firm Uniswap Labs of Potential Lawsuitwsj.com - April 10 at 6:02 PMAffinius Capital warns new SEC rules will have 'significant effect' on operationsbizjournals.com - April 9 at 8:48 PMFINRA Fines Florida B/D $500K For Not Retaining Business-Related Textswealthmanagement.com - April 8 at 2:13 PMMedia Sentiment Over TimeTop Headlines5 High-Yielding Oversold Stocks with Bullish RatingsApril 26, 2024 9:06 AMView 5 High-Yielding Oversold Stocks with Bullish RatingsHigher Oil Prices Could Give NextEra’s Stock Earnings a BoostApril 24, 2024 10:40 AMView Higher Oil Prices Could Give NextEra’s Stock Earnings a BoostPower Surge: Utilities Sector's Resilience ShinesApril 25, 2024 9:51 AMView Power Surge: Utilities Sector's Resilience Shines5 Semiconductor Giants: Navigating the Recent PullbackApril 12, 2024 9:10 AMView 5 Semiconductor Giants: Navigating the Recent PullbackMU Nears Breakout as Analysts Continue to Pound the TableMay 8, 2024 7:11 AMView MU Nears Breakout as Analysts Continue to Pound the TableAll Headlines Company DescriptionsAmerican Renal AssociatesNYSE:ARAAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.Senvest CapitalTSE:SECSenvest Capital Inc., through its subsidiaries, holds investments in equity and real estate holdings in the United States and internationally. The company invests in derivative financial instruments comprising primarily options and warrants to purchase or sell equities, equity indices and currencies, equity swaps, foreign currency forward contracts, and foreign currency futures contracts. It also has investments as minority interests in private entities whose main assets are real estate properties; and real estate income trusts and partnerships. In addition, the company invests in self-storage facilities in Spain. The company was formerly known as Sensormatic Canada Limited and changed its name to Senvest Capital Inc. in April 1991. Senvest Capital Inc. was incorporated in 1968 and is headquartered in Montreal, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
